RETA 40mg

Description:
The next-generation metabolic peptide being developed for obesity and type 2 diabetes, acting on multiple hormonal pathways involved in appetite and energy balance.

How it works:
It is a triple agonist targeting:

• GLP-1 receptors (reduces appetite, slows gastric emptying)
• GIP receptors (enhances insulin response and fat metabolism)
• Glucagon receptors (increases energy expenditure)

This combination both reduces calorie intake and increases calorie burning.

Key benefits:

• Significant weight loss potential (among the strongest in current development pipelines)
• Improved insulin sensitivity and blood sugar control
• Reduced appetite and food cravings
• Potential improvement in lipid metabolism and fatty liver markers
• Improved muscle mass and performance

Disclaimer: For research purpose only